title: Effects of portal vein clamping time on rat liver microcirculation following extended cold preservation and transplantation.
abstract: Orthotopic rat liver transplantation (ORLT) following extended cold preservation in University of Wisconsin (UW) solution has been shown to induce alterations of the hepatic microcirculation, mainly characterized by areas of no-reflow. The present study was performed to determine whether these alterations were related to the portal vein clamping time (PVCT), shown to be the main determinant of survival after ORLT. The hepatic microcirculation was evaluated using the multiple-indicator dilution curve (MIDC) technique after ORLT following 24-hour cold ischemia in UW solution. Two groups of rats were studied: one with PVCTs of less than 14 min (survival conditions) and one with PVCTs of more than 18 min (nonsurvival conditions). Four hours after ORLT, only long PVCTs were associated with small, but significant, nonperfused areas, about 10% of the liver not being perfused by water; however, in both survival and nonsurvival conditions, the sinusoidal sieving function was well-maintained in perfused areas. In addition, liver viability parameters and hepatocyte function were similarly and minimally altered. The hepatic microcirculation is minimally altered 4 h after ORLT following extended cold preservation in UW solution, whatever the survival condition. Although only found after long PVCTs, the low magnitude of areas of no-reflow should not be associated with lethal injury of the transplanted liver, a finding further supporting the concept that survival after ORLT following 24-hour cold preservation in UW solution is mainly influenced by extrahepatic factors.
authors.affiliation: Research Center, Centre Hospitalier de l'Université de Montréal, Québec, Canada.
authors.forename: K
authors.initials: K
authors.lastname: Urata
authors.forename: A
authors.initials: A
authors.lastname: Brault
authors.forename: P M
authors.initials: PM
authors.lastname: Huet
mesh_terms: D000241:Adenosine; D000493:Allopurinol; D000818:Animals; D003250:Constriction; D015925:Cryopreservation; D005978:Glutathione; D006085:Graft Survival; D007328:Insulin; D007511:Ischemia / Q000473:pathology; D008099:Liver / Q000098:blood supply / Q000473:pathology; D008102:Liver Circulation; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D008833:Microcirculation; D009926:Organ Preservation; D019188:Organ Preservation Solutions; D011169:Portal Vein; D011887:Raffinose; D051381:Rats; D011917:Rats, Inbred Lew; D015427:Reperfusion Injury / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D020858:Tissue and Organ Harvesting / Q000379:methods*
chemical_list: D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose